TGFB1 and hyperostosis: In patients with Camurati-Engelmann disease, for example, TGFβ is secreted by osteoblasts and then activated without binding to the bone matrix, leading to severe hyperostosis and osteoarthritis due to abnormal osteogenesis [23, 24].